WinstonWınston
Back
Exosens logo

Exosens

EXENS.PA
50
Electrical Equipment & Parts · Industrials
Exchange
Euronext Paris
Winston Score
50
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Strong
Stability
Strong
Valuation
Good
Dividends
Weak

Winston Score History

The full picture

Exosens is a French technology company that makes sensors and imaging systems used to see in the dark or detect things the human eye cannot. Its core products include image intensifier tubes, infrared detectors, and photon-counting sensors sold mainly to defense forces, security agencies, and scientific research organizations. The company is one of Europe's leading producers of night-vision and low-light detection components.

Exosens earns revenue primarily by selling hardware — specialized optical and electronic components — to government defense customers and industrial clients across Europe and beyond. It is headquartered in France and benefits from a strong moat built on deep technical expertise, long customer qualification cycles, and the fact that defense buyers rarely switch suppliers once a product is certified. The key growth driver is rising defense spending across NATO countries, though the business carries concentration risk given its heavy reliance on government contracts, which can be delayed or cut depending on budget decisions.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+12.7% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-45.5% YoY

YoY Growth Rate

Earnings declining

Insider Activity

36.0%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Position

Cash flow positive

€114M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Exosens is a rare growth stock that's already generating positive cash flow while growing at 13%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
12.9%
Thin — 12.9% gross margin
Profit after running costs
Operating Margin
12.4%
Healthy — 12.4% operating margin
Return on the money invested
ROCE
12.7%
Good — 12.7% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+15.1%
Fast-growing sales (+15.1% YoY)
Profit growth
EPS YoY
-50.8%
Earnings shrinking (-50.8% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
205%
Turns 205% of profit into real cash
Spare cash per sale
FCF Margin
11.4%
Modest free cash flow (11.4%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.56
Conservative — low debt load (0.56)
Covers its interest
Interest Cover
7.66x
Adequate interest coverage (7.7x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
106.0x
no trend
Expensive — P/E 106.0

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+82.9
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (106.0 → 23.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.48%
no trend
Small dividend — 0.48% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial